China-Japan Union Hospital of Jilin University, Department of Endocrinology, Jilin, China.
China-Japan Union Hospital of Jilin University, Department of Obstetrics and Gynecology, Jilin, China.
Front Endocrinol (Lausanne). 2024 Oct 21;15:1374254. doi: 10.3389/fendo.2024.1374254. eCollection 2024.
Thyroid dysfunction exhibits a heightened prevalence among people with diabetes compared to those without diabetes. Furthermore, TD emerges as a notable correlated risk factor for the onset of diabetic retinopathy.
Using data from the FinnGen database (R9), we investigated the causal relationship between thyroid dysfunction (TD) and four stages of diabetic retinopathy (DR). A two-sample univariable Mendelian randomization (UVMR) approach was employed to estimate the total causal effect of TD on four stages of DR, while multivariable Mendelian randomization (MVMR) was used to assess the direct causal effect. The meta-analysis was conducted to summarize the collective effect of TD on four stages of DR. The inverse variance weighted (IVW) method was the primary approach for Mendelian randomization analysis, with heterogeneity, horizontal pleiotropy, and leave-one-out sensitivity analyses performed to validate the robustness of the findings.
In UVMR analysis, thyrotoxicosis (TOS) was significantly associated with an increased risk of diabetic retinopathy across four stages (OR, 1.10-1.19; P<0.025). However, MVMR analysis, after adjusting for Graves' disease (GD) and/or rheumatoid arthritis (RA), revealed no significant association between TOS and the four stages of diabetic retinopathy. The Meta-analysis demonstrated the collective effect of TOS on diabetic retinopathy across all stages [OR=1.11; 95% CI (1.08-1.15); P<0.01]. In UVMR analysis, the estimates for hypothyroidism (HPT) and GD were similar to those for TOS. In the MVMR analysis, after adjusting for RA, the significant effect of HPT on DR and non-proliferative diabetic retinopathy (NPDR) remained. Additionally, MVMR analysis suggested that the estimates for GD on DR were not affected by TOS, except for GD-proliferative diabetic retinopathy (PDR). However, no significant correlation persisted after adjusting for RA, including for GD-PDR.
Our study demonstrated a significant association between thyroid dysfunction TD and DR, with the relationship being particularly pronounced in HPT-DR.
甲状腺功能障碍在糖尿病患者中的患病率高于非糖尿病患者。此外,TD 是糖尿病性视网膜病变发病的显著相关风险因素。
我们利用 FinnGen 数据库(R9)的数据,研究了甲状腺功能障碍(TD)与糖尿病性视网膜病变(DR)四个阶段之间的因果关系。采用两样本单变量孟德尔随机化(UVMR)方法估计 TD 对 DR 四个阶段的总因果效应,采用多变量孟德尔随机化(MVMR)方法评估直接因果效应。采用荟萃分析总结 TD 对 DR 四个阶段的综合影响。逆方差加权(IVW)法是孟德尔随机化分析的主要方法,进行异质性、水平多效性和逐一剔除敏感性分析,以验证结果的稳健性。
在 UVMR 分析中,甲状腺毒症(TOS)与四个阶段的糖尿病性视网膜病变风险增加显著相关(OR,1.10-1.19;P<0.025)。然而,MVMR 分析在调整格雷夫斯病(GD)和/或类风湿关节炎(RA)后,未发现 TOS 与糖尿病性视网膜病变四个阶段之间存在显著关联。荟萃分析显示 TOS 对所有阶段糖尿病性视网膜病变的综合影响[OR=1.11;95%CI(1.08-1.15);P<0.01]。在 UVMR 分析中,甲状腺功能减退症(HPT)和 GD 的估计值与 TOS 相似。在 MVMR 分析中,在调整 RA 后,HPT 对 DR 和非增生性糖尿病性视网膜病变(NPDR)的显著影响仍然存在。此外,MVMR 分析表明,GD 对 DR 的估计值不受 TOS 的影响,除了 GD-增生性糖尿病性视网膜病变(PDR)。然而,在调整 RA 后,包括 GD-PDR 在内,没有持续的显著相关性。
我们的研究表明,甲状腺功能障碍 TD 与 DR 之间存在显著关联,HPT-DR 之间的关系尤为显著。